Swiss pharmaceutical major Novartis AG has entered into a definitive agreement with private equity firm ChrysCapital to divest its entire stake in its Indian subsidiary to a consortium comprising WaveRise Investments Ltd, ChrysCapital Fund X and Two Infinity Partners. On February 19, Novartis India Ltd signed a share purchase agreement to sell around 1.75 crore […]